EAPI.PA stock closed at €1.95 on EURONEXT on 03 Mar 2026 after Euroapi published its earnings report. The share price fell 5.71% on volume of 300,664 as investors digested weaker margins and mixed cash flow signals. We summarise the earnings impact, valuation, technical signals and our model forecasts to highlight clear near-term triggers for trading and longer-term investors.

EAPI.PA stock: earnings snapshot

Euroapi S.A. reported earnings that pushed the EURONEXT-traded EAPI.PA stock to €1.95 on the close of 03 Mar 2026. The market reacted with a -5.71% intraday change and a relative volume spike of 1.45x compared with the average.

Reported per-share metrics show EPS -€1.31 and a trailing PE of -1.49, reflecting the current loss-making position. Management highlighted margin pressure and inventory timing as the main near-term headwinds.

Financials and valuation

Euroapi’s balance-sheet metrics show a strong book value per share at €10.08 and tangible book at €9.72. The market values the company at €186,047,288 market cap or €1.95 per share, so price-to-book sits near 0.21.

Operational ratios are mixed: price-to-sales is 0.22, EV-to-sales is 0.24, and operating cash flow per share is €0.67. Inventory days are elevated at 258.03, which is a working-capital risk during a margin squeeze.

Meyka AI rates EAPI.PA with a score out of 100 and forecast

Meyka AI rates EAPI.PA with a score out of 100: 64.04 (B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The external company rating reads C (Sell), showing a divergence between market-data signals and our composite model.

Meyka AI’s forecast model projects a monthly target of €2.16 (+10.77% vs €1.95), a quarterly target of €1.87 (−4.10%), and a yearly target of €1.11 (−43.24%). Forecasts are model-based projections and not guarantees.

Technical setup and trading signals

Short-term indicators show an oversold profile: RSI 29.15 and CCI -246.81. The 50-day moving average sits at €2.17, and the 200-day average at €2.85, with the stock trading below both.

Bollinger bands place near-term resistance at €2.26 and support at €2.02. Year low is €1.95, which is immediate support to watch on any follow-through selling.

Sector context, risks and opportunities

Euroapi operates in Healthcare, Medical – Devices, where peers show average metrics that are stronger than Euroapi’s current returns. The sector average PE is roughly 30.54, versus Euroapi’s negative PE.

Key risks include elevated inventory days, negative margins, and interest coverage at -3.53. Key strengths are low debt-to-equity at 0.07 and high tangible assets, which support a value case if operations stabilise.

Analyst signals, price targets and realistic scenarios

Consensus price targets are not available publicly for EAPI.PA, while the compiled company rating reads C (Sell). Given balance-sheet strength and margin weakness, we model three scenario targets: conservative €1.10, base €1.90, and bull €3.50.

A base case near €1.90 assumes modest margin recovery and stable sales. A bull case to €3.50 requires strong margin improvement and inventory normalisation. All scenarios link to changing operational performance rather than asset realisation.

Final Thoughts

EAPI.PA stock closed the session at €1.95 on EURONEXT after earnings that highlighted margin pressure and high inventory days. Our analysis balances a deep tangible book value of €10.08 per share against negative EPS and tight interest coverage. Meyka AI’s composite grade is 64.04 (B, HOLD), while short-term technicals show oversold readings and immediate support at the year low. Meyka AI’s forecast model projects a monthly target of €2.16 (implied upside +10.77%) but a one-year projection at €1.11 (implied downside -43.24%). These model outputs underline a split case: value from assets versus execution risk from operations. We recommend tracking next quarter margins, inventory reduction, and cash conversion cycles before moving from a tactical hold to a longer-term buy. This note is data-led market analysis and not financial advice. For company filings see Euroapi and for market context see Reuters

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.